Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum

详细信息    查看全文

• 作者：Christian F. Opitz ; MD^a ; ^b ; ^{c.opitz@drk-kliniken-berlin.de" class="auth_mail" title="E-mail the corresponding author} ; Marius M. Hoeper ; MD^c ; J. Simon R. Gibbs ; MD^d ; Harald Kaemmerer ; MD ; VMD^e ; Joanna Pepke-Zaba ; MD^f ; J. Gerry Coghlan ; MD^g ; Laura Scelsi ; MD^h ; Michele D&rsquo ; Alto ; MDⁱ ; Karen M. Olsson ; MD^c ; Silvia Ulrich ; MD^j ; Werner Scholtz ; MD^k ; Uwe Schulz ; MD^l ; Ekkehard Grü ; nig ; MD^m ; Carmine D. Vizza ; MDⁿ ; Gerd Staehler ; MD^o ; Leonhard Bruch ; MD^p ; Doerte Huscher ; MSc ; PhD^q ; ^r ; David Pittrow ; MD^s ; Stephan Rosenkranz ; MD^t ; ^u
• 关键词：heart failure with preserved ejection fraction ; idiopathic pulmonary arterial hypertension
• 刊名：Journal of the American College of Cardiology
• 出版年：2016
• 出版时间：26 July 2016
• 年：2016
• 卷：68
• 期：4
• 页码：368-378
• 全文大小：596 K

文摘

Pulmonary hypertension (PH) is hemodynamically classified as pre-capillary (as seen in idiopathic pulmonary arterial hypertension [IPAH]) or post-capillary (as seen in heart failure with preserved ejection fraction [HFpEF]). Overlaps between these conditions exist. Some patients present with risk factors for left heart disease but pre-capillary PH, whereas patients with HFpEF may have combined pre- and post-capillary PH.

Objectives

This study sought to further characterize similarities and differences among patient populations with either PH-HFpEF or IPAH.

Methods

We used registry data to analyze clinical characteristics, hemodynamics, and treatment responses in patients with typical IPAH (<3 risk factors for left heart disease; n = 421), atypical IPAH (≥3 risk factors for left heart disease; n = 139), and PH-HFpEF (n = 226) receiving PH-targeted therapy.

Results

Compared with typical IPAH, patients with atypical IPAH and PH-HFpEF were older, had a higher body mass index, had more comorbidities, and had a lower 6-min walking distance, whereas mean pulmonary artery pressure (46.9 ± 13.3 mm Hg vs. 43.9 ± 10.7 mm Hg vs. 45.7 ± 9.4 mm Hg, respectively) and cardiac index (2.3 ± 0.8 l/min/m² vs. 2.2 ± 0.8 l/min/m² vs. 2.2 ± 0.7 l/min/m², respectively) were comparable among groups. After initiation of targeted PH therapies, all groups showed improvement in exercise capacity, functional class, and natriuretic peptides from baseline to 12 months, but treatment effects were less pronounced in patients with PH-HFpEF than typical IPAH; with atypical IPAH in between. Survival rates at 1, 3, and 5 years were almost identical for the 3 groups.

Conclusions

Patients with atypical IPAH share features of both typical IPAH and PH-HFpEF, suggesting that there may be a continuum between these conditions.